Elsevier

Life Sciences

Volume 41, Issue 13, 28 September 1987, Pages 1547-1557
Life Sciences

Minireview
Gamma-hydroxybutyrate, a possible neurotransmitter

https://doi.org/10.1016/0024-3205(87)90721-1Get rights and content

First page preview

First page preview
Click to open first page preview

References (87)

  • R.H. Roth et al.

    Biochem. Pharmacol.

    (1970)
  • J.D. Doherty et al.

    Analytical Biochem.

    (1975)
  • R.H. Roth

    Biochem. Pharmacol.

    (1970)
  • T. Niwa et al.

    J. Chromatogr.

    (1982)
  • W.N. Fishbein et al.

    J. Biol. Chem.

    (1964)
  • B. Tabakoff et al.

    Biochem. Biophys. Res. Commun.

    (1975)
  • J.F. Rumigny et al.

    FEBS Lett.

    (1980)
  • J.F. Rumigny et al.

    FEBS Lett.

    (1981)
  • D. Weissmann-Nanopoulos et al.

    Neurochem. Intern.

    (1984)
  • R.H. Roth et al.

    Biochem. Pharmacol.

    (1968)
  • R. Maxwell et al.

    Biochem. Pharmacol.

    (1972)
  • O.C. Snead et al.

    Biochem. Pharmacol.

    (1982)
  • S.P. Bessman et al.

    Biochem. Pharmacol.

    (1972)
  • S.A. Barker et al.

    Biochem. Pharmacol.

    (1985)
  • J. Benavides et al.

    Life Sci.

    (1982)
  • E. Hosli et al.

    Neurosci. Lett.

    (1983)
  • M. Maitre et al.

    Biochem. Biophys. Res. Commun.

    (1983)
  • J. Levine et al.

    Biochem. Pharmacol.

    (1985)
  • G. Gessa et al.

    Life Sci.

    (1966)
  • R. Roth et al.
  • R. Roth et al.

    Brain Res.

    (1980)
  • C. Altar et al.

    Neuropharmacology

    (1984)
  • R. Roth et al.

    Biochem. Pharmacol.

    (1977)
  • P. Waldmeier et al.

    Eur. J. Pharmacol.

    (1978)
  • H.R. Olpe et al.

    Europ. J. Pharmacol.

    (1979)
  • L. Hosli et al.

    Neurosci. Lett.

    (1983)
  • M. Godschalk et al.

    Neurosci. Lett.

    (1976)
  • M. Godschalk et al.

    Europ. J. Pharmacol.

    (1977)
  • O.C. Snead

    Developm. Brain Res.

    (1984)
  • R. Godbout et al.

    Life Sci.

    (1982)
  • R.K. Margolis

    Biochem. Pharmacol.

    (1969)
  • E.E. Kaufman et al.

    J. Biol. Chem.

    (1981)
  • Ph. Vayer et al.

    FEBS Lett.

    (1985)
  • C.R. Lee

    Biochem. Med.

    (1977)
  • Ph. Vayer et al.

    Biochem. Pharmacol.

    (1985)
  • W. Fishbein et al.

    J. Biol. Chem.

    (1966)
  • R.J. Marcus et al.

    Int. J. Neuropharmacol.

    (1967)
  • H. Laborit et al.

    Aggressologie

    (1960)
  • J.M. Jouany et al.

    Aggressologie

    (1960)
  • H. Laborit et al.

    Neuro-Psychopharmacology

    (1961)
  • J.D. Doherty et al.

    J. Pharmacol. Experim. Ther.

    (1978)
  • M. Eli et al.

    J. Neurochem.

    (1983)
  • O.C. Snead et al.

    Developm. Brain Res.

    (1981)
  • Cited by (179)

    • Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use

      2015, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Despite this, GHB has been widely used among the body-building community and is believed by some to have been the primary focus of GHB misuse in the mid-1990s in the USA (Friedman et al., 1996) and Sweden (EMCDDA, 2002). GHB's ability to decrease body fat makes its use attractive as a means of weight loss (Chin et al., 1992; Friedman et al., 1996; Luby et al., 1992; Vayer et al., 1987). GHB has also been used as an appetite suppressant (EMCDDA, 2002).

    View all citing articles on Scopus
    View full text